Background Although self-injectable subcutaneous depot medroxyprogesterone acetate (DMPA-SC) has demonstrated promise, there are significant barriers in promoting initiation and continued use in low-resource settings.
Grace W. Kimemia +10 more
doaj +1 more source
Contraceptive efficacy and safety of DMPA-SC [PDF]
openaire +1 more source
Education as an enabler, not a requirement: ensuring access to self-care options for all
Caitlin Corneliess +5 more
doaj +1 more source
This formative assessment, conducted in 2023, was an exploratory qualitative inquiry designed to understand potential user, service provider and stakeholder perspectives on how to offer, introduce and support the use of DMPA-SC self-injection in ways that meet the needs and interests of women in Punjab, Pakistan.
Qayyum, Kanwal +7 more
openaire +1 more source
Consistency of on-the-job training implementation for subcutaneous depot medroxyprogesterone acetate in Ghana and associated healthcare worker knowledge transfer: A cross-sectional mixed-methods study. [PDF]
Porter Erlank C +6 more
europepmc +1 more source
Alleviating price and information barriers to long-acting contraception uptake in Kenyan pharmacies using patient and provider incentives: a cluster randomized control trial. [PDF]
Dieci M, Paramo C, Gertler PJ.
europepmc +1 more source
Erratum for: Odwe et al., Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels: Pilot Results From 4 Districts of Uganda. [PDF]
europepmc +1 more source
Barriers and Facilitators to Expanding User-Administered Injectable Contraceptives in the United States. [PDF]
Clark C, Cheng AL, Creason L, Karlin J.
europepmc +1 more source

